Article
New York - Recent data suggests that refinements in dosing techniques can improve clinical outcomes with alefacept (Amevive, Biogen).
Chilukuri’s Approach to Safer Aesthetic Treatments
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
The Future of Pediatric Care at MOPD
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
ICYMI: Allergan Unveils AA Signature Program for Personalized Treatment
Merz Aesthetics Publishes Results of Global Confidence Study